Thiamine seed treatment enhances LOX expression, promotes growth and induces downy mildew disease resistance in pearl millet

Seeds of pearl millet (Pennisetum glaucum) susceptible cv. 7042S were treated with thiamine at 5, 10, 15, 20 and 25 mM concentrations, and growth promotion and downy mildew resistance were tested. Seed treatment with 20 mM thiamine resulted in 72 and 70 % disease protection under greenhouse and fiel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biologia plantarum 2011-09, Vol.55 (3), p.522-527
Hauptverfasser: Pushpalatha, H.G., University of Mysore (India). Dept. of Studies in Biotechnology, Sudisha, J., University of Mysore (India). Dept. of Studies in Biotechnology, Geetha, N.P., University of Mysore (India). Dept. of Studies in Biotechnology, Amruthesh, K.N., University of Mysore (India). Dept. of Studies in Botany, Shekar Shetty, H., University of Mysore (India). Dept. of Studies in Biotechnology
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Seeds of pearl millet (Pennisetum glaucum) susceptible cv. 7042S were treated with thiamine at 5, 10, 15, 20 and 25 mM concentrations, and growth promotion and downy mildew resistance were tested. Seed treatment with 20 mM thiamine resulted in 72 and 70 % disease protection under greenhouse and field conditions, respectively, and enhanced vegetative and reproductive growth parameters. Analysis of lipoxygenase (LOX) activity in inoculated pearl millet seedlings at different time intervals indicated that increased LOX activity was initiated at 3 h after inoculation (hai) and maximum activity was observed at 24 hai. Northern analysis showed that LOX mRNA transcript accumulation was higher in the resistant seedlings (cv. IP18292) than in susceptible seedlings. Thiamine seed treatment induces rapid LOX gene expression and results in significant disease protection against downy mildew disease.
ISSN:0006-3134
1573-8264
1573-8264
DOI:10.1007/s10535-011-0118-3